Cite
Abstract 11846: Baseline Coronary Flow Velocity Predicts Adverse Outcomes in Women With Suspected Ischemia and No Obstructive Coronary Arteries: Results From the Women's Ischemia Syndrome Evaluation (WISE) Long-Term Follow-Up.
MLA
Wei, Janet, et al. “Abstract 11846: Baseline Coronary Flow Velocity Predicts Adverse Outcomes in Women With Suspected Ischemia and No Obstructive Coronary Arteries: Results From the Women’s Ischemia Syndrome Evaluation (WISE) Long-Term Follow-Up.” Circulation, vol. 138, Nov. 2018, p. A11846. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135767781&authtype=sso&custid=ns315887.
APA
Wei, J., Shufelt, C., Cook-Wiens, G., Samuels, B., Petersen, J. W., Anderson, R. D., Azarbal, B., Henry, T. D., Handberg, E. M., Sopko, G., Pepine, C. J., & Bairey Merz, C. N. (2018). Abstract 11846: Baseline Coronary Flow Velocity Predicts Adverse Outcomes in Women With Suspected Ischemia and No Obstructive Coronary Arteries: Results From the Women’s Ischemia Syndrome Evaluation (WISE) Long-Term Follow-Up. Circulation, 138, A11846.
Chicago
Wei, Janet, Chrisandra Shufelt, Galen Cook-Wiens, Bruce Samuels, John W Petersen, R. David Anderson, Babak Azarbal, et al. 2018. “Abstract 11846: Baseline Coronary Flow Velocity Predicts Adverse Outcomes in Women With Suspected Ischemia and No Obstructive Coronary Arteries: Results From the Women’s Ischemia Syndrome Evaluation (WISE) Long-Term Follow-Up.” Circulation 138 (November): A11846. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=135767781&authtype=sso&custid=ns315887.